Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Interest & Investment Income (2019 - 2023)

Historic Interest & Investment Income for Korro Bio (KRRO) over the last 5 years, with Q3 2023 value amounting to $448000.0.

  • Korro Bio's Interest & Investment Income rose 2763.53% to $448000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $1.8 million, marking a year-over-year increase of 8604.41%. This contributed to the annual value of $1.3 million for FY2022, which is 23425.69% up from last year.
  • Per Korro Bio's latest filing, its Interest & Investment Income stood at $448000.0 for Q3 2023, which was up 2763.53% from $346000.0 recorded in Q2 2023.
  • In the past 5 years, Korro Bio's Interest & Investment Income ranged from a high of $942000.0 in Q4 2019 and a low of $25000.0 during Q1 2021
  • For the 5-year period, Korro Bio's Interest & Investment Income averaged around $306263.2, with its median value being $178000.0 (2020).
  • Data for Korro Bio's Interest & Investment Income shows a peak YoY increase of 61717.17% (in 2020) and a maximum YoY decrease of 9660.3% (in 2020) over the last 5 years.
  • Quarter analysis of 5 years shows Korro Bio's Interest & Investment Income stood at $942000.0 in 2019, then plummeted by 96.6% to $32000.0 in 2020, then skyrocketed by 156.25% to $82000.0 in 2021, then soared by 456.1% to $456000.0 in 2022, then dropped by 1.75% to $448000.0 in 2023.
  • Its Interest & Investment Income stands at $448000.0 for Q3 2023, versus $346000.0 for Q2 2023 and $523000.0 for Q1 2023.